Revance Therapeutics Inc (RVNC)

[10nisman]

So he was running the aesthetic launch and it went poorly so they decided to put him in charge of the launch of the larger theraputic indication. Smart. /s

The key takeaway is Foley took swift action (removing Dustin and shifting strategy). With respect to Dustin's future role... Executives make incorrect strategy calls all the time, and thinking Dustin has no right ever working again because of it seems extreme. The therapeutic strategy should be straightforward compared to aesthetics, and maybe Dustin is the right guy to lead and execute. Maybe he's not. We will know soon enough. I think we can be confident Foley's level of focus has never been higher and based on prior history, the team does its best work during times like these.